Pro-Dex Q3 revenue rises 15% on higher handpiece shipments

Pro-Dex

30/04/2026 21:13

Overview

US surgical device maker's fiscal Q3 revenue rose 15% yr/yr on higher handpiece shipments

Net income and EPS rose, aided by a $2.3 mln gain from Monogram Technologies rights

Gross margin fell 2 points to 31% due to unfavorable product mix; operating expenses rose 41%

Outlook

Company did not provide specific guidance for the current quarter or full year

Result Drivers

NEXT GENERATION HANDPIECE SHIPMENTS - Higher shipments to largest customer drove revenue growth

APM ACQUISITION COSTS - Higher operating expenses due to acquisition-related costs and personnel expenses

UNFAVORABLE PRODUCT MIX - Gross margin declined due to less favorable product mix

Company press release: ID:nACSyL2w8a

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
$19.95 mln
Q3 EPS
$1.20
Q3 Net Income
$3.94 mln
Q3 Gross Profit
$6.13 mln
Q3 Operating Expenses
$3.04 mln


Analyst Coverage

Wall Street's median 12-month price target for Pro-Dex Inc is $56.00, about 12.4% above its April 29 closing price of $49.84

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)